China joins COVAX, UN-backed global COVID-19 vaccine facility | China

China is the largest economy to have supported the initiative to date. Neither the United States nor Russia have signed up.

China has officially signed an agreement to join the World Health Organization-led COVAX facility, a global COVID-19 vaccine project, to ensure poorer countries have access to life-saving vaccines.

China is the largest economy to have supported the initiative to date. Neither the United States nor Russia have signed up.

Foreign Ministry spokeswoman Hua Chunying said in a statement posted on Twitter that China’s decision was “an important step in upholding the concept of a common health community for all and pledging its commitment to transforming COVID-19 vaccines into a global good appreciate “.

The COVID-19 Vaccines Global Access Facility (COVAX) is led by the World Health Organization (WHO), the Coalition for Innovation in Epidemic Preparation (CEPI) and Gavi, the Vaccine Alliance, and aims to deliver around two billion doses of vaccine worldwide deliver by the end of next year.

COVAX will pool financial and scientific resources and bring together richer countries with 92 low and middle income economies such as the Philippines and Indonesia eligible for funding for vaccine procurement through the Gavi COVAX Advance Market Commitment (AMC).

“Serious Threat”

COVAX aims to develop at least three safe and effective vaccines that can be made available to participants in the program.

Earlier this month, United Nations secretary-general Antonio Guterres reiterated his call for a “quantum leap in support” of the global vaccination schedule, saying he needed an additional $ 15 billion in funding by the end of the year.

China is joining COVAX as countries in Europe, the United States and beyond to combat the resurgence of the virus that first emerged in the central Chinese city of Wuhan late last year.

The United States recorded the most cases and the most deaths, but did not support COVAX, but secured supplies through bilateral deals.

Hundreds of thousands of people in China have already been injected with experimental vaccines, with at least three companies in the final stages of clinical trials.

The government has announced it may have a coronavirus vaccine available as soon as next month, and Hua said priority would be given to developing countries.

“The COVID-19 pandemic still poses a serious threat to the safety and health of people in all countries,” she said. “China continues to focus on ensuring that developing countries have equal access to appropriate, safe and effective vaccines.”